Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR)

Iván J Núñez-Gil1, Enrico Cerrato2, Mario Bollati3

  • 1Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain; Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain.

Insights

Coronary artery aneurysms are relatively common, often linked to coronary stenosis and cardiovascular risk factors. Treatment with antiplatelet therapy and percutaneous coronary intervention is generally safe and effective.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Interventional Cardiology

Background:

  • Coronary artery aneurysms are focal dilations of coronary arteries, with reported prevalence varying widely.
  • Despite potential clinical significance, coronary artery aneurysms are not well-documented in practice guidelines.
  • Limited data exists on the prevalence, management strategies, and long-term outcomes of coronary artery aneurysms.

Purpose of the Study:

  • To investigate the prevalence of coronary artery aneurysms.
  • To analyze the management approaches for patients with coronary artery aneurysms.
  • To evaluate the long-term clinical outcomes in patients diagnosed with coronary artery aneurysms.

Main Methods:

  • A retrospective analysis of 436,467 coronary angiograms from 2004-2016 was conducted.
  • Data from 1565 patients with coronary artery aneurysms were collected from 32 hospitals across 9 countries.
  • Patient demographics, aneurysm characteristics, treatment interventions, and clinical outcomes were analyzed.

Main Results:

  • The global prevalence of coronary artery aneurysms was found to be 0.35%.
  • Most affected patients were male (78.5%) with a mean age of 65 years, presenting frequently with acute coronary syndrome.
  • Aneurysms were often associated with coronary stenosis and aortopathies; percutaneous coronary intervention (PCI) was the commonest revascularization strategy.

Conclusions:

  • Coronary artery aneurysms are a notable finding, frequently co-occurring with coronary stenosis and significant cardiovascular risk.
  • Antiplatelet therapy is considered a reasonable management strategy.
  • Percutaneous coronary intervention demonstrates safety and efficacy in managing coronary artery aneurysms.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
909
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
387
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
220
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
340
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
601
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
381